Suc-Leu-Leu-Val-Tyr-AMC
CAS: 94367-21-2
Ref. 3D-FS110535
2mg | 211.00 € | ||
5mg | 343.00 € | ||
10mg | 503.00 € | ||
50mg | 1,033.00 € | ||
100mg | 1,458.00 € |
Product Information
- Chymotrypsin Substrate III
- Fluorogenic
- N-succinyl-leu-leu-val-tyr 7-amido-4-*methylcouma
- Succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide
- Llvy-mca
- N-Succinyl-leu-leu-val-tyr-7-amido-4-methylcoumarin
- Sllvt-mca
- Suc-leu-leu-val-tyr-7-amino-4-methylcoumarin
- Suc-leu-leu-val-tyr-mca
- Suc-llvy-mca
- See more synonyms
- L-Tyrosinamide, N-(3-carboxy-1-oxopropyl)-L-leucyl-L-leucyl-L-valyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-
- N-(3-carboxypropanoyl)leucylleucyl-L-valyl-N-(4-methyl-2-oxo-2H-chromen-7-yl)-L-tyrosinamide
Suc-Leu-Leu-Val-Tyr-AMC is a cyclin D2 inhibitor that binds to the proteasome and inhibits its function. It has been shown to be useful for the treatment of cancerous tissues as it inhibits the production of prostaglandin J2, which is involved in the progression of cancer cells. Suc-Leu-Leu-Val-Tyr-AMC has also been shown to have antioxidant properties and can inhibit oxidative injury. This drug may be used to prevent or treat various diseases such as Parkinson's disease, Alzheimer's disease, Huntington's disease, diabetes mellitus type II, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and septic shock.
Chemical properties
Technical inquiry about: 3D-FS110535 Suc-Leu-Leu-Val-Tyr-AMC
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.